The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.
600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar
Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.
As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?
Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.
If scientific storytelling alone can impact health outcomes, then how can we apply that knowledge in practice?
More than other patient groups, they want a deeper, ongoing relationship with caregivers.
More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign
Consent forms and reimbursement are the main deterrents of offering the service.
The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.
Too often marketers get caught up in their own company, brand, or workforce as the hero of their own story.
Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.
The deal highlights ongoing interest in the influential point-of-care market.
FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.
Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles
Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.
Funding for patient-assistance charities makes up 7% of operating expenses for drugmakers; Avanir ad under fire; Trump to consider Medicare rebates
HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?
Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.
Jeff Ceitlin is CCO of HVH Patient Precision Analytics.
Adrian Aoun is the CEO and founder of Forward.
Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.
We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.
Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD
Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.
As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.
In short, he'll be further along the learning curve than anyone ever tapped for the nation's number-one public health regulatory slot.